ArticleProceedings of the National Academy of Sciences of the United States of America2017

CRISPR-Cas9-based treatment of myocilin-associated glaucoma.

Ankur Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.